Literature DB >> 12032879

Incorporating quality of life measures in HIV clinical trials.

Maria K Lin1, Albert W Wu, Dennis A Revicki.   

Abstract

PURPOSE: To increase awareness regarding issues specific to health-related quality of life (HRQL) assessments for investigators designing clinical trials and for clinicians reading published reports on clinical trials. HQRL measures are becoming more prevalent, alongside conventional therapeutic and laboratory endpoints. However, they differ from these physiologic or biologic measurements because HRQL data are subjective. We discuss the criteria for selecting and implementing HRQL instruments to optimize the usefulness of HRQL assessments in clinical studies.
METHOD: We conducted a review of selected design and measurement issues that should be considered when planning for the use of HRQL instruments in HIV/AIDS clinical trials.
CONCLUSION: When used appropriately, HRQL measures can indicate the impact of HIV treatment on patient functioning and well-being and can help to inform clinicians about treatment effects.

Entities:  

Mesh:

Year:  2002        PMID: 12032879     DOI: 10.1310/Q8H1-67TH-UBMX-KDMW

Source DB:  PubMed          Journal:  HIV Clin Trials        ISSN: 1528-4336


  6 in total

1.  Psychometric evaluation of the functional assessment of HIV Infection (FAHI) questionnaire and its usefulness in clinical trials.

Authors:  Muriel Viala-Danten; Dominique Dubois; Hélène Gilet; Silas Martin; Katrien Peeters; David Cella
Journal:  Qual Life Res       Date:  2010-05-28       Impact factor: 4.147

Review 2.  Does palliative care improve outcomes for patients with HIV/AIDS? A systematic review of the evidence.

Authors:  R Harding; D Karus; P Easterbrook; V H Raveis; I J Higginson; K Marconi
Journal:  Sex Transm Infect       Date:  2005-02       Impact factor: 3.519

3.  [Effects of distress and coping on quality of life in HIV-positive patients: results of a longitudinal study].

Authors:  P Leiberich; M Brieger; K Schumacher; P Joraschky; E Olbrich; H Loew; K Tritt
Journal:  Nervenarzt       Date:  2005-09       Impact factor: 1.214

Review 4.  Health-related quality of life assessment after antiretroviral therapy: a review of the literature.

Authors:  Harleen Gakhar; Amanda Kamali; Mark Holodniy
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

Review 5.  Longitudinal and cross sectional assessments of health utility in adults with HIV/AIDS: a systematic review and meta-analysis.

Authors:  Bach Xuan Tran; Long Hoang Nguyen; Arto Ohinmaa; Rachel Marie Maher; Vuong Minh Nong; Carl A Latkin
Journal:  BMC Health Serv Res       Date:  2015-01-22       Impact factor: 2.655

6.  Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study.

Authors:  D Podzamczer; N Rozas; P Domingo; C Miralles; E Van den Eynde; A Romero; E Deig; H Knobel; J Pasquau; A Antela; B Clotet; P Geijo; E Rodríguez de Castro; M A Casado; A Muñoz; A Casado
Journal:  Curr HIV Res       Date:  2018       Impact factor: 1.581

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.